nitrohydroxyiodophenylacetate has been researched along with Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuusela, P; Mäkelä, O; Péterfy, F | 1 |
| Bindon, CI; Brüggemann, M; Hale, G; Waldmann, H | 1 |
2 other study(ies) available for nitrohydroxyiodophenylacetate and Hemolysis
| Article | Year |
|---|---|
Affinity requirements for antibody assays mapped by monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antibody Affinity; Chemical Precipitation; Dinitrophenols; Enzyme-Linked Immunosorbent Assay; Hemagglutination Tests; Hemolysis; Hybridomas; Mice; Nitrohydroxyiodophenylacetate; Radioimmunoassay | 1983 |
Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.
Topics: Antibodies, Monoclonal; Complement Activating Enzymes; Complement Activation; Complement C1; Complement C1q; Complement C3; Complement C3b; Complement C4; Complement C4b; Erythrocyte Membrane; Erythrocytes; Haptens; Hemolysis; Humans; Immunoglobulin G; Immunoglobulin Isotypes; Nitrohydroxyiodophenylacetate | 1988 |